Neighbors sue owner of Old Town pulp mill, claiming it 'has never smelled so bad'
A class-action lawsuit alleges ND Paper has been negligent by allowing the mill to emit a rotten-egg odor that's getting worse.
Source: pressherald.com
Page 7 - Christopher Causey News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Christopher Causey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Christopher Causey Today - Breaking & Trending Today
United Therapeutics (NASDAQ:UTHR) Downgraded to "Buy" at StockNews.com
StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Get Rating) from a strong-buy rating to a buy rating in a report issued on Monday. Several other research analysts also recently issued reports on UTHR. HC Wainwright upped their price objective on United Therapeutics from $248.00 to $255.00 and gave the stock a buy rating in […]
Source: etfdailynews.com
United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit
Report available at corporateresponsibility.unither.comSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its third annual Corporate Responsibility Report with 2021 highlights, providin...
Source: pharmiweb.com
United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report
12.09.2022 - United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its third annual Corporate Responsibility Report with 2021 highlights, providing stakeholders important information regarding the ...
Source: wallstreet-online.de
American Century Companies Inc. Acquires 62,576 Shares of United Therapeutics Co. (NASDAQ:UTHR)
American Century Companies Inc. lifted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 904.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,496 shares of the biotechnology company’s stock after acquiring an additional 62,576 shares during the […]
Source: etfdailynews.com